Why is aseptic processing important in pharmaceutical manufacturing? The manufacturing of both sterile drugs and biological products can be achieved through terminal sterilization or aseptic ...

Lee, MA, March 28, 2023 (GLOBE NEWSWIRE) -- Berkshire Sterile Manufacturing (BSM), a fill finish CDMO located in Lee, MA, recently completed their first GMP fill using their new low loss fill process.

Shawn Kinney, the co-founder and CEO of Berkshire Sterile Manufacturing, says the company's one-of-a-kind filling system contains features that are particularly useful for drugs that are especially ...

LEE — Berkshire Sterile Manufacturing is putting the finishing touches on its new, state-of-the-art production line, the centerpiece of the firm’s $20 million expansion project. But receiving and ...

Sterile manufacturing refers to the method of producing medications in which the drug product, container, and closure are meticulously sterilized before being distributed. The pharmaceutical sector ...

According to the National Cancer Institute, immunotherapies that enlist and strengthen the power of a patient’s immune system are the “fifth pillar” of cancer treatment adding to surgery, chemotherapy ...

Dalton Pharma Services today announced that it has expanded it cGMP sterile powder filling capabilities as part of its ongoing focus of sterile manufacturing, supported by FedDev Ontario funding.

An aging patient population and an increasingly consumer-driven healthcare environment fuel the demand for quick, convenient surgical procedures. The tools used in these procedures are more ...

After years of manufacturing woes, Pfizer appeared to turn a corner earlier this year for its growing sterile injectables portfolio. But even with signs trending upward, Pfizer is preparing to exit an ...

Central sterile processing is essential for a safe and efficient operating room. Mistakes in sterilization can cause delays in surgery and patient infections, among other issues. Alecia Cooper, RN, BS ...

The sterile injectables CDMO market is poised for growth due to the rising demand for biologics, biosimilars, and advanced injectable formats. Opportunities include expansion in large molecule and ...

The US Food and Drug Administration (FDA) has issued warning letters to several drug manufacturers and compounders for violations of current good manufacturing practices (CGMP) and for marketing ...